Passage BIO
- Biological Products, Except Diagnostic Substances
- Philadelphia, Pennsylvania
Compensation history
Top executives at Passage BIO received an average of $3M per person in annual compensation from 2019 to 2023.
Average pay of disclosed executives at Passage BIO
By year
- 2022
BG$3MBruce GoldsmithFormer President and Chief Executive OfficerAF$2MAlex FotopoulosChief Technical OfficerMT$2MMonika Maria ToernsenFormer Chief Commercial OfficerSK$2MSimona KingChief Financial OfficerEC$1MEdgar B. Chip CaleGeneral Counsel and Former Interim Chief Executive OfficerWC$1MWilliam ChouPresident and Chief Executive Officer- 2021
ES$7MEliseo SalinasFormer Chief of Research and DevelopmentBG$5MBruce GoldsmithChief Executive Officer and PresidentJQ$4MJill QuigleyFormer Chief Operating OfficerSK$4MSimona KingChief Financial OfficerEC$3MEdgar B. Chip CaleGeneral Counsel and Former Interim Chief Executive OfficerAF$3MAlex FotopoulosChief Technical OfficerMT$3MMonika Maria ToernsenFormer Chief Commercial Officer
Executives
We found 11 executives who work or worked at Passage BIO.
William Chou
Passage BIO
Chief Executive Officer
Edgar Cale
Passage BIO
General Counsel
Mark Forman
Passage BIO
Chief Medical Officer
Alex Fotopoulos
Passage BIO
Former Chief Technical Officer
Simona King
Passage BIO
Chief Financial Officer
Bruce Goldsmith
Passage BIO
Chief Executive Officer
Monika Toernsen
Passage BIO
Former Chief Commercial Officer
Eliseo Salinas
Passage BIO
Former Chief of Research and Development
News
Passage BIO CEO William Chou's 2023 pay rises 12% to $1.4M
April 9, 2024
Passage BIO CEO Bruce Goldsmith's 2022 pay falls 50% to $2.6M
April 14, 2023
Passage BIO Former Chief of Research and Development Eliseo Salinas receives $6.6M in 2021
April 14, 2022
Passage BIO CEO Bruce Goldsmith receives $17M in 2020
April 14, 2021
About Passage BIO
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- AddressOne Commerce Square, 2005 Market Street, 39th Floor, Philadelphia, Pennsylvania 19103
- Phone2678660312
- Fiscal year endDecember 31
Source: SEC filings on April 9, 2024, April 14, 2023, and April 14, 2021.